Feasibility Study of Bolus 5-Fluorouracil+L-Leucovorin as Salvage Line Chemotherapy for Oral Fluorouracil-Resistant Unresectable Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group Study HGCSG1502 | Zendy

Tetsuhito Muranaka | Zendy; Yoshito Komatsu | Zendy; Masataka Yagisawa | Zendy; Kentaro Sawada | Zendy; Kazuaki Harada | Zendy; Yasuyuki Kawamoto | Zendy; Hiroshi Nakatsumi | Zendy; Satoshi Yuki | Zendy; Kota Ono | Zendy; Shuhei Kawahata | Zendy; Yoshimitsu Kobayashi | Zendy; Susumu Sogabe | Zendy; Takuto Miyagishima | Zendy; Kazuteru Hatanaka | Zendy; Takahide Sasaki | Zendy; Masayoshi Dazai | Zendy; Ichiro Iwanaga | Zendy; Atsushi Ishiguro | Zendy; Michio Nakamura | Zendy; Naoya Sakamoto | Zendy; Yuh Sakata | Zendy

Open Access

Feasibility Study of Bolus 5-Fluorouracil+L-Leucovorin as Salvage Line Chemotherapy for Oral Fluorouracil-Resistant Unresectable Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group Study HGCSG1502

Author(s) -

Tetsuhito Muranaka,

Yoshito Komatsu,

Masataka Yagisawa,

Kentaro Sawada,

Kazuaki Harada,

Yasuyuki Kawamoto,

Hiroshi Nakatsumi,

Satoshi Yuki,

Kota Ono,

Shuhei Kawahata,

Yoshimitsu Kobayashi,

Susumu Sogabe,

Takuto Miyagishima,

Kazuteru Hatanaka,

Takahide Sasaki,

Masayoshi Dazai,

Ichiro Iwanaga,

Atsushi Ishiguro,

Michio Nakamura,

Naoya Sakamoto,

Yuh Sakata

Publication year - 2017

Publication title -

journal of clinical trials

Language(s) - English

Resource type - Journals

ISSN - 2167-0870

DOI - 10.4172/2167-0870.1000337

Subject(s) - fluorouracil , medicine , bolus (digestion) , cancer , chemotherapy , oncology , gastrointestinal cancer , gastroenterology , colorectal cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research